Glucosamine does not appear to rebuild cartilage that has already been lost, but there is evidence it can slow cartilage breakdown. The distinction matters: slowing loss is not the same as regrowth. In lab settings, glucosamine promotes the production of cartilage building blocks, yet translating that into meaningful cartilage restoration in a living human joint has proven far more difficult. The clinical picture is genuinely mixed, with some trials showing structural protection and major medical organizations recommending against its use.
What Glucosamine Does Inside a Joint
Your body naturally produces glucosamine, an amino sugar that serves as a raw ingredient for the structural molecules that make up cartilage. These molecules, called glycosaminoglycans, form the gel-like matrix that gives cartilage its cushioning ability. Glucosamine production is actually the rate-limiting step in building this matrix, meaning it’s the bottleneck in the whole assembly process. The idea behind supplementation is simple: flood the system with more raw material to keep cartilage production running smoothly.
In lab experiments using cartilage cells grown in dishes, glucosamine does increase production of key cartilage components, including aggrecan (the main structural protein in cartilage) and type II collagen (the fiber that gives cartilage its tensile strength). It also appears to counteract some of the damage caused by inflammation. When inflammatory signals suppress a key enzyme needed for building cartilage chains, glucosamine can partially reverse that suppression in a dose-dependent way. So at the cellular level, the biological logic checks out.
The problem is that a petri dish is not a knee. By the time you swallow a glucosamine pill and it passes through your digestive system, only a fraction reaches the joint. Oral bioavailability for the sulfate form is about 9.4%, meaning roughly 90% of what you take never makes it into your bloodstream in usable form.
What Clinical Trials Actually Show
The strongest structural evidence comes from two three-year trials that measured joint space width on X-rays, a standard proxy for cartilage thickness. In both studies, participants taking 1,500 mg of glucosamine sulfate daily showed essentially no joint space narrowing over three years. The placebo groups, by contrast, lost 0.31 mm and 0.19 mm respectively. That difference was statistically significant. A meta-analysis of these and related data concluded that glucosamine sulfate may delay the radiological progression of knee osteoarthritis when taken daily for two to three years.
A separate six-year study using MRI to measure actual cartilage volume found that people taking glucosamine combined with chondroitin sulfate had significantly less cartilage loss in the knee, particularly in the lateral (outer) compartment. The protective effect was tied to how long people stayed on the supplements, becoming significant only in those who took them for at least two years. This is important context: if you’re expecting results in weeks or even months, the evidence doesn’t support that timeline.
Biomarker studies offer another angle. Urinary markers of cartilage breakdown (fragments of type II collagen released when cartilage degrades) dropped significantly after six months and one year of glucosamine and chondroitin use. Lower levels of these markers suggest the cartilage is breaking down more slowly, though not necessarily rebuilding.
Why Major Guidelines Still Recommend Against It
Despite these positive findings, both the American College of Rheumatology and the Osteoarthritis Research Society International issued strong recommendations against glucosamine for knee osteoarthritis in 2019. Their reasoning: the best overall body of evidence doesn’t show important clinical benefits. This isn’t as contradictory as it sounds. Many of the largest and most rigorous trials, particularly those using the hydrochloride form of glucosamine or looking at pain reduction as the primary outcome, found no meaningful difference from placebo.
The positive structural trials were mostly conducted with a specific prescription-grade crystalline glucosamine sulfate preparation that isn’t what most people buy off the shelf. Over-the-counter glucosamine products vary widely in formulation, purity, and actual glucosamine content, which makes it difficult to generalize from tightly controlled clinical trials to what you’d pick up at a pharmacy.
Sulfate vs. Hydrochloride: The Form Matters
Glucosamine supplements come in two main forms, and they don’t perform equally. Glucosamine sulfate achieves higher concentrations in the synovial fluid (the lubricating fluid inside your joints) compared to glucosamine hydrochloride at the same dose. In one head-to-head comparison, synovial fluid levels were significantly higher at both one and six hours after taking the sulfate form. Twelve hours later, glucosamine levels in both blood and joint fluid were still elevated above baseline with the sulfate version but had already returned to baseline with the hydrochloride.
Nearly all the positive structural trials used glucosamine sulfate. The large GAIT trial, which found mostly negative results and heavily influenced the guideline recommendations, used glucosamine hydrochloride. This distinction between forms is one of the main reasons experts continue to disagree about glucosamine’s value.
How Long It Takes and What Dose to Use
The standard dose used in clinical trials is 1,500 mg of glucosamine sulfate per day, typically taken as a single dose. Most studies showing structural benefits ran for at least two to three years, and the six-year MRI study found that the cartilage-preserving effect only became significant after at least two years of consistent use. This is not a fast-acting supplement. If it works at all for cartilage preservation, it works slowly and requires long-term commitment.
For symptom relief (reduced pain and stiffness), some trials report improvements starting around four to eight weeks, though this varies considerably between individuals and many trials show no pain benefit at all.
Combining With Chondroitin or MSM
Glucosamine is frequently sold in combination with chondroitin sulfate, and the six-year MRI study that found reduced cartilage loss specifically used this combination. Chondroitin is itself a glycosaminoglycan, one of the structural molecules that glucosamine helps build, so there’s a biological rationale for pairing them. In the biomarker study, the combination that also included type II collagen produced more consistent and lasting reductions in cartilage degradation markers over one year compared to glucosamine and chondroitin alone.
MSM (methylsulfonylmethane) is another common addition, though clinical evidence specifically linking MSM to measurable cartilage preservation is thin. It may contribute modest anti-inflammatory effects, but the structural story for glucosamine rests primarily on glucosamine sulfate with or without chondroitin.
Blood Sugar Considerations
Because glucosamine is an amino sugar, there has been concern about its effect on blood sugar regulation. A systematic review found mixed results: four studies detected decreased insulin sensitivity or increased fasting glucose in people taking glucosamine, three of which used oral supplements. The effect was more likely to appear in people who already had impaired glucose tolerance or insulin resistance at the start. If you have diabetes or prediabetes, this is worth monitoring, though many people with normal blood sugar regulation show no changes.
The Bottom Line on Cartilage
Glucosamine does not regrow cartilage. No supplement does. Once cartilage is significantly worn, the body has very limited ability to replace it, with or without supplementation. What some evidence supports is a more modest but still meaningful claim: glucosamine sulfate, taken at 1,500 mg daily for at least two years, may slow the rate at which cartilage is lost in osteoarthritic knees. The cells that maintain cartilage do respond to glucosamine in the lab, biomarkers of cartilage breakdown do decrease, and some long-term imaging studies show preserved cartilage volume. But the effect is incremental, not dramatic, and depends heavily on using the sulfate form, maintaining consistent use over years, and possibly starting before cartilage loss is too advanced.